The Latest Breaking News from Tobacco

The death of an innocent beloved burlesque performer after a home she was in was set alight in a case of mistaken identity has been linked to tobacco gang wars.

New Zealand’s smokefree law was hailed around the world for creating a smokefree generation that would have lifelong protection from smoking’s harms.

The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this weekend

Massachusetts outlawed flavored tobacco. Now, just as criminal justice groups warned, a vape shop owner is serving time.

Shares fell as much 9% as it revealed a slight decline in US vape sales, which it has touted as the future of the smoking industry.

With Trump’s tariff strategy giving U.S. brands a competitive edge, Bank of America sees these two names as key beneficiaries.

Tobacco giant Philip Morris has significantly outperformed the broader market over the past year and analysts remain bullish on the stock’s prospects.

Cancer is a major health concern worldwide accounting for nearly 1 in every 6 deaths, as per WHO. But did you know that nearly 50% of cancer cases can be prevented by making simple lifestyle changes? There are some factors like smoking, poor diet, lack of physical activity, and exposure…

When it comes to the highest cancer-related mortalities in India, lung cancer has emerged as the major health burden in the past couple of years. According to the Lancet Report, India accounted for 72,510 lung cancer cases and 66,279 deaths in 2020. This can be attributed to the rising air…

The market for consumer essentials and necessities is growing rapidly, thanks to the resilient demand and increasing sustainable practices, making consumer staples stocks ideal for investors following defensive investing. Amid this, robust consumer staples stocks PepsiCo (PEP), Philip Morris International (PM), and Kimberly-Clark (KMB) could be ideal buys for defensive…

Altria outperformed the broader market over the past year, yet Wall Street analysts remain cautious about the stock’s prospects.